Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet
NCT06369571Phase 2Enrolling by invitation
- Sponsor
- Johns Hopkins University
- Start
- Oct 2024
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of atorvastatin in dyslipidemia (2 arms), sponsored by Johns Hopkins University. Primary endpoints: Diet adherence as assessed by 3 day food records, Statin Adherence at 12 weeks and 3 more. Started Oct 2024; status: enrolling by invitation.
02
Drugs
atorvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT06369571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06369571.